PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 30559731-0 2018 Transcriptional Landscape of a bla KPC-2 Plasmid and Response to Imipenem Exposure in Escherichia coli TOP10. Imipenem 65-73 beta-lactamase Escherichia coli 31-34 30559731-3 2018 Using E. coli TOP10 strain harboring a multi-replicon IncFIIK-IncFIB bla KPC-2-gene carrying plasmid pBIC1a from K. pneumoniae ST-258 clinical isolate BIC-1, we aimed to identify basal gene expression and the effects of imipenem exposure using whole transcriptome approach by RNA sequencing (RNA-Seq). Imipenem 220-228 beta-lactamase Escherichia coli 69-72 29776449-2 2018 In this study, the first evaluation of MBL genes, bla IMP and bla VIM , in Escherichia coli resistant to imipenem isolated from urine and blood specimens in Qom, Iran is described. Imipenem 105-113 beta-lactamase Escherichia coli 50-53 29776449-2 2018 In this study, the first evaluation of MBL genes, bla IMP and bla VIM , in Escherichia coli resistant to imipenem isolated from urine and blood specimens in Qom, Iran is described. Imipenem 105-113 beta-lactamase Escherichia coli 62-65 29776449-6 2018 PCR was also carried out to determine the presence of bla IMP and bla VIM genes in imipenem-resistant isolates. Imipenem 83-91 beta-lactamase Escherichia coli 54-57 29776449-6 2018 PCR was also carried out to determine the presence of bla IMP and bla VIM genes in imipenem-resistant isolates. Imipenem 83-91 beta-lactamase Escherichia coli 66-69 24132992-8 2014 Bla(Mab) hydrolysed imipenem more efficiently (k(cat)/K(m) = 3.0 x 10(4) M(-1) s(-1)), indicating that the in vivo activity of this drug might be improved by combination with a beta-lactamase inhibitor. Imipenem 20-28 beta-lactamase Escherichia coli 0-3 21153909-6 2011 Susceptibility testing performed on recombinant strains carrying the bla(KPC-3) gene with or without the insertion revealed that minimum inhibitory concentrations of imipenem, meropenem, cefepime, and cefotaxime for E. coli EMU-KPC3 (without insertion) were four times higher than that of E. coli EKPC3 (with insertion). Imipenem 166-174 beta-lactamase Escherichia coli 69-72 19141739-6 2009 Due to the acquisition of bla(IMP-1), the susceptibility of E. coli transconjugants to imipenem, meropenem, panipenem and biapenem decreased by 32-, 256-, 64- and 128-fold, respectively. Imipenem 87-95 beta-lactamase Escherichia coli 26-29 19141739-8 2009 Strains harbouring bla(IMP-10) showed higher-level resistance to imipenem, meropenem and panipenem than the strains harbouring bla(IMP-1), although the nucleotide sequences of the class 1 integrons carrying bla(IMP-10) and bla(IMP-1) were identical except for a single point mutation. Imipenem 65-73 beta-lactamase Escherichia coli 19-22 18184647-6 2008 RESULTS: The 24 isolates with positive EDTA/imipenem synergy tests had bla(VIM-1) carried on 40-150 kb plasmids. Imipenem 44-52 beta-lactamase Escherichia coli 71-74 18222954-7 2008 RESULTS: In 30 bla(VIM)-positive isolates that exhibited MICs of imipenem < or = 4 mg/L, MBL Etest could not be evaluated. Imipenem 65-73 beta-lactamase Escherichia coli 15-18 11257029-8 2001 The gene, bla(KPC-1), was cloned in E. coli and shown to confer resistance to imipenem, meropenem, extended-spectrum cephalosporins, and aztreonam. Imipenem 78-86 beta-lactamase Escherichia coli 10-13